---
schema_version: "secwatch.filing_event.v1"
accession: "0001906324-26-000003"
form_type: "8-K"
ticker: "QDEL"
cik: "0001906324"
company_name: "QuidelOrtho Corp"
filed_at: "2026-02-11T23:59:59+00:00"
generated_at: "2026-05-16T03:23:35.664789+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# QuidelOrtho reports FY25 revenue $2.73B, adjusted EBITDA $597M; guides FY26 revenue $2.7-2.9B

## Summary
- FY25 total revenue $2.73B in line with guidance; Labs revenue +6% as reported, non-respiratory +5% ex Donor Screening.
- GAAP net loss $1.13B includes $701M goodwill impairment; adjusted diluted EPS $2.12 (in range $2.00-$2.15).
- Adjusted EBITDA margin expanded 240 bps to 22%; adjusted EBITDA $597M (in range $585-$605M).
- FY26 guidance: revenue $2.7-2.9B, adjusted EBITDA $630-670M (23.3% margin), free cash flow $120-160M.
- Q4 revenue $724M, adjusted EBITDA $153M, adjusted EPS $0.46; Labs +8% as reported.

## SEC filing metadata
- accession: 0001906324-26-000003
- form_type: 8-K
- ticker: QDEL
- cik: 0001906324
- company_name: QuidelOrtho Corp
- filed_at: 2026-02-11T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1906324/000190632426000003/0001906324-26-000003-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1906324/000190632426000003/qdel-20260211.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001906324-26-000003
- JSON: https://secwatch.observer/filing/0001906324-26-000003.json
- Plain text: https://secwatch.observer/filing/0001906324-26-000003.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.